Mabpharm Limited (2181.HK)
HKD 0.5
(3.13%)
HKD 0.5
(3.13%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 57.39 Million | -56.88 Million | -199.47 Million | -147.23 Million | -136.61 Million | -61.87 Million |
| Net Income | -209.35 Million | -210.81 Million | -291.74 Million | -184.63 Million | -202.52 Million | -152.59 Million |
| Depreciation & Amortization | 60.69 Million | 51.54 Million | 43.87 Million | 24.39 Million | 22.19 Million | 11.71 Million |
| Deferred income taxes | 1.45 Million | - | 6.67 Million | 31.92 Million | -15.69 Million | 3.26 Million |
| Stock-based compensation | 13.46 Million | 9.78 Million | 12.24 Million | 12.4 Million | 13.84 Million | 5.44 Million |
| Change in working capital | 181.7 Million | 81.99 Million | 29.03 Million | -25.81 Million | 41.78 Million | 65.94 Million |
| Other non-cash items | 9.42 Million | 10.6 Million | 449 Thousand | -5.51 Million | 3.77 Million | 4.34 Million |
| Investing Cash Flow | -3.5 Million | -104.95 Million | -179.41 Million | 155.99 Million | -413.09 Million | -82.7 Million |
| Investments in PPE | -19.04 Million | -125.12 Million | -148.66 Million | -197.24 Million | -113.56 Million | -90.89 Million |
| Acquisitions | - | - | - | 12.89 Million | - | - |
| Investment purchases | - | -15 Million | - | -45.01 Million | -180.67 Million | - |
| Sales/Maturities of investments | 15.38 Million | - | - | 224.35 Million | - | - |
| Other Investing Activities | 151 Thousand | 35.17 Million | -30.75 Million | 161 Million | -118.84 Million | 8.19 Million |
| Financing Cash Flow | 85.59 Million | 112.26 Million | -17.78 Million | -80.47 Million | 922.75 Million | 256.81 Million |
| Debt repayment | -2.25 Million | -8.16 Million | -15.34 Million | -63.08 Million | -136.98 Million | -30 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | 1.03 Billion | 410.48 Million |
| Other Financing Activities | -26 Million | 120.42 Million | -2.43 Million | -17.39 Million | 26.47 Million | -153.66 Million |
| Accounts receivables | -10.31 Million | -8.85 Million | -793 Thousand | - | - | - |
| Accounts payables | 10.31 Million | 8.85 Million | 793 Thousand | - | - | - |
| Inventory | -1.24 Million | -47.58 Million | -19.79 Million | -11.22 Million | 5.05 Million | 7.92 Million |
| Other working capital | 182.94 Million | 129.58 Million | 48.82 Million | -14.58 Million | 36.73 Million | 58.01 Million |
| Cash at beginning of period | 33.56 Million | 81.55 Million | 484.84 Million | 588.72 Million | 198.19 Million | 76.44 Million |
| Cash at end of period | 173.34 Million | 33.56 Million | 81.55 Million | 484.84 Million | 588.72 Million | 198.19 Million |
| Capital Expenditure | -19.04 Million | -125.12 Million | -148.66 Million | -197.24 Million | -113.56 Million | -90.89 Million |
| Effect of forex changes on cash | 293 Thousand | 1.59 Million | -6.62 Million | -32.16 Million | 17.47 Million | -2.42 Million |
| Net cash flow / Change in cash | 139.77 Million | -47.98 Million | -403.29 Million | -103.87 Million | 390.52 Million | 121.75 Million |
| Free Cash Flow | 38.35 Million | -182.01 Million | -348.13 Million | -344.47 Million | -250.18 Million | -152.77 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -48.78 Million | -48.78 Million | -54.67 Million | -209.35 Million | -54.67 Million | -49.99 Million |
| Depreciation & Amortization | 15.58 Million | 15.58 Million | 16.5 Million | 60.69 Million | 16.5 Million | 13.84 Million |
| Deferred income taxes | - | - | - | 1.45 Million | - | -75.64 Million |
| Stock-based compensation | 3.85 Million | 3.85 Million | 3.89 Million | 13.46 Million | 3.89 Million | 2.83 Million |
| Change in working capital | -19.64 Million | -19.64 Million | 10.99 Million | 181.7 Million | 10.99 Million | -17.56 Million |
| Other non-cash items | 16.9 Million | 16.9 Million | 68.74 Million | 9.42 Million | 68.74 Million | 34.11 Million |
| Investing Cash Flow | -6.14 Million | -6.14 Million | -5.76 Million | -3.5 Million | -5.76 Million | 4 Million |
| Investments in PPE | -6.31 Million | -6.31 Million | -5.96 Million | -19.04 Million | -5.96 Million | -3.55 Million |
| Acquisitions | - | - | - | - | - | -7.56 Million |
| Investment purchases | - | - | - | - | - | -62.2 Million |
| Sales/Maturities of investments | - | - | - | 15.38 Million | - | 79.28 Million |
| Other Investing Activities | 165 Thousand | 165 Thousand | 207 Thousand | 151 Thousand | 207 Thousand | 7.56 Million |
| Financing Cash Flow | -11.4 Million | -11.4 Million | 35.11 Million | 85.59 Million | 35.11 Million | 7.68 Million |
| Debt repayment | - | - | - | -2.25 Million | - | -21.98 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -11.4 Million | -11.4 Million | 35.11 Million | -26 Million | 35.11 Million | 7.68 Million |
| Accounts receivables | -22.74 Million | -22.74 Million | 4.89 Million | -10.31 Million | 4.89 Million | -10.05 Million |
| Accounts payables | - | - | - | 10.31 Million | - | 15.32 Million |
| Inventory | 167 Thousand | 167 Thousand | 600 Thousand | -1.24 Million | 600 Thousand | -1.22 Million |
| Other working capital | 2.93 Million | 2.93 Million | 5.49 Million | 182.94 Million | 5.49 Million | -6.29 Million |
| Cash at beginning of period | - | - | - | 33.56 Million | - | 37.68 Million |
| Cash at end of period | -49.63 Million | -49.63 Million | 75.1 Million | 173.34 Million | 75.1 Million | 24.96 Million |
| Capital Expenditure | -6.31 Million | -6.31 Million | -5.96 Million | -19.04 Million | -5.96 Million | -3.55 Million |
| Effect of forex changes on cash | 4000.00 | 4000.00 | 284.5 Thousand | 293 Thousand | 284.5 Thousand | -138 Thousand |
| Net cash flow / Change in cash | -49.63 Million | -49.63 Million | 75.1 Million | 139.77 Million | 75.1 Million | -12.72 Million |
| Free Cash Flow | -38.4 Million | -38.4 Million | 39.49 Million | 38.35 Million | 39.49 Million | -20.32 Million |
E25
CDW
FULC
BR
IAC
6857